Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Wilkie

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Cancer Research|June 3, 2009
CAR mechanics: driving T cells into the MUC of cancerJohn Maher, Scott Wilkie
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2002
RB activation defect in tumor cell linesCristina Broceño, Scott Wilkie, Sibylle Mittnacht
Veterinary Therapeutics : Research in Applied Veterinary Medicine|February 14, 2003
Plasma concentrations of enrofloxacin and its active metabolite ciprofloxacin in dogs following single oral administration of enrofloxacin at 7.5, 10, or 20 mg/kgDawn Merton Boothe, Albert Boeckh, Harry W Boothe, et al.
Biotechnology and Bioengineering|May 28, 2011
Transforming growth factor-β1 is constitutively secreted by Chinese hamster ovary cells and is functional in human cellsRichard Beatson, Daisy Sproviero, John Maher, et al.
Veterinary Therapeutics : Research in Applied Veterinary Medicine|September 25, 2003
Dosing regimen and hematologic effects of pentoxifylline and its active metabolites in normal dogsChristine A Rees, Dawn M Boothe, Albert Boeckh, et al.
American Journal of Veterinary Research|November 9, 2005
Evaluation of the concentration of marbofloxacin in alveolar macrophages and pulmonary epithelial lining fluid after administration in dogsHarry W Boothe, Sarah A Jones, W Scott Wilkie, et al.
Immunity|November 17, 2016
Targeting of Tumor-Associated Glycoforms of MUC1 with CAR T CellsJohn Maher, Scott Wilkie, David M Davies, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2008
Retargeting of human T cells to tumor-associated MUC1: the evolution of a chimeric antigen receptorScott Wilkie, Gianfranco Picco, Julie Foster, et al.
The Journal of Biological Chemistry|June 22, 2010
Selective expansion of chimeric antigen receptor-targeted T-cells with potent effector function using interleukin-4Scott Wilkie, Sophie E Burbridge, Laura Chiapero-Stanke, et al.
Journal of Clinical Immunology|April 21, 2011
Trafficking of CAR-engineered human T cells following regional or systemic adoptive transfer in SCID beige miceAna Caterina Parente-Pereira, Jerome Burnet, David Ellison, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Cancer Research|June 3, 2009
CAR mechanics: driving T cells into the MUC of cancerJohn Maher, Scott Wilkie
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2002
RB activation defect in tumor cell linesCristina Broceño, Scott Wilkie, Sibylle Mittnacht
Veterinary Therapeutics : Research in Applied Veterinary Medicine|February 14, 2003
Plasma concentrations of enrofloxacin and its active metabolite ciprofloxacin in dogs following single oral administration of enrofloxacin at 7.5, 10, or 20 mg/kgDawn Merton Boothe, Albert Boeckh, Harry W Boothe, et al.
Biotechnology and Bioengineering|May 28, 2011
Transforming growth factor-β1 is constitutively secreted by Chinese hamster ovary cells and is functional in human cellsRichard Beatson, Daisy Sproviero, John Maher, et al.
Veterinary Therapeutics : Research in Applied Veterinary Medicine|September 25, 2003
Dosing regimen and hematologic effects of pentoxifylline and its active metabolites in normal dogsChristine A Rees, Dawn M Boothe, Albert Boeckh, et al.
American Journal of Veterinary Research|November 9, 2005
Evaluation of the concentration of marbofloxacin in alveolar macrophages and pulmonary epithelial lining fluid after administration in dogsHarry W Boothe, Sarah A Jones, W Scott Wilkie, et al.
Immunity|November 17, 2016
Targeting of Tumor-Associated Glycoforms of MUC1 with CAR T CellsJohn Maher, Scott Wilkie, David M Davies, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2008
Retargeting of human T cells to tumor-associated MUC1: the evolution of a chimeric antigen receptorScott Wilkie, Gianfranco Picco, Julie Foster, et al.
The Journal of Biological Chemistry|June 22, 2010
Selective expansion of chimeric antigen receptor-targeted T-cells with potent effector function using interleukin-4Scott Wilkie, Sophie E Burbridge, Laura Chiapero-Stanke, et al.
Journal of Clinical Immunology|April 21, 2011
Trafficking of CAR-engineered human T cells following regional or systemic adoptive transfer in SCID beige miceAna Caterina Parente-Pereira, Jerome Burnet, David Ellison, et al.
Pageof 2